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Cellular/Molecular
Pharmacologically Distinct Nicotinic Acetylcholine
Receptors Drive Efferent-Mediated Excitation in
Calyx-Bearing Vestibular Afferents
X J. Chris Holt,1,2,3 Kevin Kewin,1 XPaivi M. Jordan,1 Peter Cameron,4Marcin Klapczynski,4
J. Michael McIntosh,5 Peter A. Crooks,6 Linda P. Dwoskin,7 and XAnna Lysakowski4
1Department of Otolaryngology, 2Department of Neurobiology and Anatomy, and 3Department of Pharmacology and Physiology, University of Rochester,
Rochester, New York 14642, 4Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60612, 5Department of Psychiatry,
University of Utah, Salt Lake City, Utah 84112, 6Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences,
Little Rock, Arkansas 72205, and 7College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536
Electrical stimulation of vestibular efferent neurons rapidly excites the resting discharge of calyx/dimorphic (CD) afferents. In turtle, this
excitation ariseswhen acetylcholine (ACh), released fromefferent terminals, directly depolarizes calyceal endings by activating nicotinic
ACh receptors (nAChRs). Althoughmolecular biological data from the peripheral vestibular system implicatemost of the known nAChR
subunits, specific information about those contributing to efferent-mediated excitation of CD afferents is lacking. We sought to identify
the nAChR subunits that underlie the rapid excitation of CD afferents and whether they differ from 910 nAChRs on type II hair cells
that drive efferent-mediated inhibition in adjacent bouton afferents. We recorded from CD and bouton afferents innervating the turtle
posterior crista during electrical stimulation of vestibular efferents while applying several subtype-selective nAChR agonists and antag-
onists. The910nAChRantagonists,-bungarotoxin and-conotoxinRgIA, blocked efferent-mediated inhibition in bouton afferents
while leaving efferent-mediated excitation in CDunits largely intact. Conversely, 5-iodo-A-85380, sazetidine-A, varenicline,-conotoxin
MII, and bPiDDB (N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide) blocked efferent-mediated excitation in CD afferents without
affecting efferent-mediated inhibition in bouton afferents. This pharmacological profile suggested that calyceal nAChRs contain6 and
2, but not9, nAChR subunits. Selective blockade of efferent-mediated excitation in CD afferents distinguished dimorphic from calyx
afferents by revealing type II hair cell input. Dimorphic afferents differed in having higher mean discharge rates and a mean efferent-
mediated excitation thatwas smaller in amplitude yet longer in duration.Molecular biological data demonstrated the expression of9 in
turtle hair cells and 4 and 2 in associated vestibular ganglia.
Key words: ACh; 6 nAChR; 9 nAChR; calyx; vestibular afferent; vestibular efferent
Introduction
Cholinergic vestibular efferent neurons (VENs) originate bilater-
ally in the dorsal brainstem and send axons via cranial nerve VIII
to innervate the vestibular end organs (Meredith, 1988; Lysa-
kowski and Goldberg, 2004).Within the neuroepithelium, VENs
undergo extensive branching to give rise to many presynaptic
varicosities that appose hair cells and afferent processes (Smith
and Rasmussen, 1968; Sans andHighstein, 1984; Lysakowski and
Goldberg, 1997; Purcell and Perachio, 1997). Electrical stimula-
tion of VENs rapidly inhibits and/or excites the resting discharge
of most vestibular afferents (Goldberg and Ferna´ndez, 1980;
Rossi et al., 1980; Highstein and Baker, 1985; Brichta and Gold-
berg, 2000b). A preponderance of pharmacological data suggests
that the release of acetylcholine (ACh) and activation of nicotinic
ACh receptors (nAChRs) underlie these rapid inhibitory and ex-
citatory responses (Guth et al., 1998; Holt et al., 2011).
Efferent-mediated inhibition of vestibular afferents is initi-
ated by the activation of910 nAChRs in type II hair cells (Holt
et al., 2001, 2006b). Calcium influx through 910 nAChRs ac-
tivates calcium-dependent potassium channels (SKs), resulting
in hair cell hyperpolarization, reduction in transmitter release,
and inhibition of afferent firing (Oliver et al., 2000; Elgoyhen et
al., 2001; Weisstaub et al., 2002). Consistent with such mecha-
nisms, efferent-mediated inhibition is blocked by 910 nAChR
antagonists, including 3-tropanylindole-3-carboxylate [ICS-205,390
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(ICS)] and-bungarotoxin (BTX), and is converted to excitation by
SK blockers. Furthermore, convergence of RT-PCR, in situ hy-
bridization (ISH), and immunohistochemical (IHC) data con-
firms the9 nAChR subunit is expressed by type II hair cells (Hiel
et al., 1996; Lustig et al., 1999; Holt et al., 2001; Kong et al., 2006).
Efferent-mediated excitation of vestibular afferents is attrib-
uted to enhancement of transmitter release from type II hair cells
(Rossi et al., 1980; Bernard et al., 1985; Sugai et al., 1991) or direct
afferent depolarization (Highstein and Baker, 1985; Holt et al.,
2006b). Both forms of excitation are potently blocked by the
nAChR antagonist dihydro--erythroidine (DHE), but show a
limited sensitivity to 910 nAChR antagonists (Guth et al.,
2002; Holt et al., 2003, 2006b). The simplest interpretation of
these pharmacological data is that efferent-mediated afferent ex-
citation uses nAChRs distinct from 910. To this end, ISH and
RT-PCR studies have implicated a number of other nAChR sub-
units in vestibular ganglia and end organs (Wackym et al., 1995;
Zoli et al., 1995;Hiel et al., 1996; Anderson et al., 1997).However,
labeling with 9 antibodies and BTX, as well as recent pharma-
cological data, suggests that afferent processes also express910
nAChRs (Ishiyama et al., 1995;Wackym et al., 1995; Dailey et al.,
2000; Luebke et al., 2005; Yu et al., 2014).
In this paper, electrophysiological recordings were acquired
from turtle posterior crista afferents in response to electrical
stimulation of efferent fibers during the application of selective
nAChR compounds. The goals were as follows: (1) to resolve
whether 910 nAChRs are involved in efferent-mediated exci-
tation of calyx/dimorphic (CD) afferents; (2) to identify what
other nAChR subunits play a role; and (3) to determine whether
calyx and dimorphic afferents differ in their responses to efferent
stimulation.
Materials andMethods
Tissue preparation. Red-eared slider turtles (Trachemys scripta elegans,
100–500 g, 7–18 cm carapace length) of either sex were deeply anes-
thetized with sodium pentobarbital. Upon loss of reflexes, turtles were
decapitated and the head was split along the mid-sagittal plane. The two
halves were immediately placed in an oxygenated control solution con-
taining the following (in mM): 105 NaCl, 4 KCl, 0.8 MgCl2, 2 CaCl2, 25
NaHCO3, 2 Na-pyruvate, 0.5 glutamine, 10 glucose, pH 7.2–7.3, during
continuous bubbling with 95% O2/5% CO2. Only the left half was used
for nerve recordings (Holt et al., 2006a,b). For RNA-DNA studies, ves-
tibular end organs and ganglia were extracted from both halves, dis-
sected, and transferred to ice-cold RNAlater (Ambion). Inner ear tissues
intended for protein studies were placed in 1 Tris-buffered saline
(TBS) containing a protease inhibitor mixture (catalog #P2714, Sigma-
Aldrich) and immediately frozen on dry ice. For ISH and IHC proce-
dures, vestibular tissue was prepared by either extracting whole
labyrinths from the inner ear and drop-fixing in 4% paraformaldehyde
(PFA), or perfusing the labyrinth with 4% PFA, 1% acrolein, 1% picric
acid, and 5% sucrose in control solution before extraction. The latter
fixation was used for ISH and immunohistochemistry for nAChR sub-
units. All procedures involving animals were in accordance with recom-
mendations made by NIH’s Guide for the Care and Use of Laboratory
Animals and approved by the University Committee for Animal Re-
sources at the University of Rochester and by the Institutional Animal
Care and Use Committee at the University of Illinois at Chicago.
Nerve recording setup.Methods were similar to those described in pre-
vious papers (Holt et al., 2006a,b, 2007). All neurophysiological proce-
dures were conducted at room temperature (RT; 21–23°C). The brain
was blocked transversely between the levels of the trigeminal and glosso-
pharyngeal nerves. These nerves and surrounding bone were then re-
moved to provide direct access to the bony plate over the posterior
ampulla. A small fenestra was made to gain access to the main posterior
ampullary nerve and its branches to each hemicrista. Several layers of
connective tissue covering the nerve were then removedwith a fine tung-
sten hook. The half-head was mounted in a recording chamber and the
posterior ampullary nerve was continuously superfused with oxygenated
control solution from a gravity-fed pipette capable of delivering solu-
tions at 3–4 l/s from any one of six 10 ml reservoirs.
Borosilicate microelectrodes (40–100 M; Sutter Instruments) were
filled with 3 M KCl and connected to a preamplifier (Biomedical Engi-
neering), which neutralized microelectrode capacitance by driving the
shield of the input cable. Microelectrodes were advanced in 5 m steps
with a Burleigh Inchworm drive mounted on a three-axis micromanip-
ulator (EXFO Burleigh Products). Recordings were made from the pos-
terior ampullary nerve just as it bifurcates to innervate the two
hemicristae (Holt et al., 2006a,b).
Efferent stimulation. Electrical stimulation of efferent fibers was used
to classify afferents (Brichta and Goldberg, 2000b; Holt et al., 2006b). All
efferent fibers destined for the posterior crista, but none of the afferents,
travel in a small nerve bundle, or cross-bridge, running between the
anterior and posterior divisions of the VIIIth nerve (Fayyazuddin et al.,
1991). Access to the bundle was made possible by removing a bony
section of the roof of themouth just rostral to the lagena. To avoidmuscle
contractions during stimulation, jaw muscles were removed and the fa-
cial nerve was severed at its bony entrance into the middle ear. Efferent
stimulating electrodes were constructed from Teflon-coated silver wires
(AG10T, Medwire), insulated except for the last 0.5 mm chlorided tip.
One electrode was placed on the cross-bridge while a second electrode
was placed on nearby bone. Electrical stimuli consisted of trains of 100s
constant-current shocks delivered from a stimulus isolator (model A360,
World Precision Instruments) to the two electrodes. The cross-bridge
electrode was the cathode. Efferent shock artifacts were canceled off-line
after computing an average artifact and subtracting it from the corre-
sponding records.
Data acquisition and computer processing.Data acquisition and efferent
stimuli were controlled using a PCwith custom-made Spike2 scripts and
micro1401 interface (Cambridge ElectronicDesign).Microelectrode sig-
nals were low-pass filtered at 1 kHz (four-pole Bessel; model 432,
Wavetek) and sampled at 10 kHz by a 12-bit analog-to-digital converter.
Delivery of efferent shock trains was controlled from a digital-output
port. Spike2 data files were first exported as general text files and then
processed using custom macros written in IgorPro 6.36 (WaveMetrics).
Physiological testing and response analysis. In all afferent recordings,
2–5 s of background activity were recorded before our standard efferent
stimulus, a shock train consisting of 20 shocks at 200Hz, was delivered to
the efferent nerve fibers in the cross-bridge. Several trains were presented
and shock amplitude was adjusted so as to provide a clear response
devoid of any antidromic activation. Stimulus thresholds (Ts) typically
ranged from 15 to 100 A and maximal current intensities ranged from
40 to 300 A (2–3  T ). Mean spike responses to efferent stimulation
were calculated by averaging 10–25 trials. The result was displayed as an
average response histogram. The mean amplitude of efferent-mediated
excitation or inhibition was calculated from the first 100 ms segment of
the average response histogram immediately following the efferent shock
train (Brichta and Goldberg, 2000b). Intertrial intervals were 3–5 s to
allow afferent discharge to return to prestimulus values before delivery of
the next efferent shock train.
Efferent-mediated effects on hair cells alter ongoing quantal activity in
the afferent nerve fiber. Characterization of such activity during efferent
stimulation is instructive in distinguishing efferent actions in hair cells
versus direct efferent actions on afferents (Rossi et al., 1994; Holt et al.,
2006a,b). To characterize quantal activity, we relied on shot-noise the-
ory, which assumes that the shapes of individual quantal events are ste-
reotyped and their occurrence follows Poisson statistics. FollowingRice’s
(1944) extension of Campbell’s theorem, the first three central moments
[i.e., mean (1), variance (2), and skew (3)], are related to the quantal
rate (qrate, ), quantal size (qsize, h), and the shape of individual quanta
[f(t), t 0] using the following equation (Eq. 1):
n  h
nIn
Here and in subsequent equations, angle brackets indicate expected val-
ues, superscripts are exponents, and subscripts are indices. I1, I2, and I3
are integrals of the following form (Eq. 2):
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where f(t) is normalized to a peak value of unity. In this paper, ensemble
means (1) were obtained from the original voltage records. Ensemble
variances (2) and ensemble skews (3) were extracted after first digitally
high-pass filtering (single-pole, corner frequency of 1000 rad/s, 159 Hz)
the original records. When using filtered data, f(t) in Equation 2 was
normalized before filtering.
Modulation of either qsize or qrate can result in variance changes. We
exploited the relation between 3 and 2 to distinguish between the two
modulations during efferent stimulation, where a variation in qrate leads
to a linear relation as expressed in the following equation (Eq. 3):

3
 hI
3
/I
3
	
2
.
Meanwhile, qsize variation, with other parameters remaining un-
changed, gives a nonlinear relation as expressed in the following equation
(Eq. 4):
3
2  I3
2/I2
3	2
3
Residual variance (Rvar), defined as the variance remaining once quantal
activity has been suppressed (i.e., 3 
 0), is attributed to instrumental
noise (Holt et al., 2007; Goldberg and Holt, 2013). The total ensemble
variance was corrected for instrumental noise by subtracting Rvar. To
estimate Rvar, we obtained the ensemble skew–variance relation from
high-pass records for points within the first second after delivery of the
efferent shock train. A linear regression of these points was extrapolated
to zero skew to obtain Rvar. Using the extrapolation to estimate the Rvar
was more reliable in afferents where there was an efferent-mediated de-
crease in 2 and 3. We then plotted the ensemble skew against the
corrected ensemble variance in double-logarithmic coordinates. When
fitted with a log–log regression line, slopes near 1 (i.e., unity) were indic-
ative of changes in qrate whereas slopes near 1.5 were interpreted as
changes in qsize (Holt et al., 2006a,b).
To study the effects of efferent stimulation on synaptic activity during
intracellular recordings, two different approaches were used: (1) QX-314
[2-(triethylamino)-N-(2,6-dimethylphenyl) acetamide; 40 mM], a charged
lidocaine derivative, was added to themicropipette solution to block spikes
in the recorded afferent; or (2) ensemble measurements were made after
spikes were digitally removed off-line and replaced with a blank interval.
In the latter approach, sufficient prespike and postspike intervals were
also blanked so that estimates of synaptic variancewere not influenced by
the spike and subsequent afterhyperpolarization. Intracellular record-
ings were analyzed only if the membrane potential was more negative
than40mV.To avoid contamination from shock artifacts,mean values
of voltage and variance were calculated from an 80 ms segment taken 20
ms after termination of the efferent shock train. Ensemblemeasurements
were tabulated from 10 to 25 efferent shock presentations.
Solutions. -BTX, DHE, 1,1-dimethyl-4-piperazinium (DMPP), ICS,
and QX-314 were obtained from Sigma-Aldrich. 5-iodo-A-85380 (5-iodo),
cytisine, methyllycaconitine (MLA), sazetidine-A (SazA), and varenicline
were from Tocris Cookson. QX-314 was dissolved in 3 M KCl and stored
as frozen 40 mM aliquots. All other drugs were prepared as concentrated
stock solutions in ultrafiltered water, which were then added to the con-
trol solution to achieve the desired concentrations before each experi-
ment. -Conotoxin RgIA (-CtxRgIA), -conotoxin MII (-CtxMII),
and bPiDDB (N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide)
were synthesized as previously described (Cartier et al., 1996; Ayers et al.,
2002; Vincler et al., 2006) and also obtained from Tocris Bioscience.
Most pharmacological agents usually took 30 s to 2 min to begin acting
and another 2–5 min to reach maximal effect. Washout times were vari-
able and could be 10 min. Application (i.e., wash-in) and wash-out
times were frequently longer for peptide toxins presumably due to their
larger molecular weights. Drug reversibility for most compounds was
demonstrated within a single afferent recording session with the excep-
tion of 5-iodo, SazA, and varenicline. Recovery from SazA was demon-
strated with subsequent recordings in the same preparation, whereas
reversibility from 5-iodo and varenicline was not observed. Receptor
selectivity, measures of potency (IC50), and the range of concentrations
used in this study are shown in Table 1.
Statistical procedures. All statistical analyses were done in Graph Pad
Prism (GraphPad Software). Unless otherwise stated, values are ex-
pressed asmeans SEM.One-sample t test was used to evaluate whether
means differed from zero. Drug effects were evaluated by a paired t test.
An unpaired t test was used to determine whether the amplitude and
duration of efferent-mediated excitation as well as the background dis-
charge rate differed between calyx and dimorphic afferents.
IHC studies. Freshly fixed semicircular canal cristae were placed in
30% sucrose for1 h at 4°C, and then embedded in a gelatinmold (12%
gelatin prepared in 30% sucrose) and chilled at 4°C. Upon solidification,
the gelatin block was mounted on the stage of a freezing sliding mi-
crotome and 35–40m frozen sections were subsequently cut and trans-
ferred to a collection vial. The collection vial was warmed to dissolve the
Table 1. List of cholinergic drugs used in this study
Compounda
nAChR subunit
selectivityb
EC50 /IC50
range (nM)c
Range in this study
(M)d Referencese
Agonists
Cytisine 42*,62* 2–200 0.3–1 Capelli et al., 2011; Marks et al., 2010; Papke et al., 2011
DMPP Nonselective 420–64,000 5–25 Briggs and McKenna, 1998; Chavez-Noriega et al., 1997
5-iodo 42,62*,34 76–794 0.01–3 Capelli et al., 2011; Carbone et al., 2009
SazA 42,62* 0.2–36 0.01–3 Capelli et al., 2011; Xiao et al., 2006; Zwart et al., 2008
Varenicline 42*,62*,7 h 1.6–334 0.1–0.3 Capelli et al., 2011; Coe et al., 2005; Papke et al., 2011; Peng et al., 2013
Antagonists
BTX 7*,8,9* 1–10 1–3 Elgoyhen et al., 1994, 2001; Gerzanich et al., 1994; Goutman et al., 2005; Zwart et al., 2014
-CtxMII 32*,62*,34 0.5–316 2 Capelli et al., 2011; Cartier et al., 1996; Harvey et al., 1997; McClure-Begley et al., 2012; McIntosh et al., 2004
-CtxRgIA 910 1.5–490 0.333–1.67 Azam and McIntosh, 2012; Ellison et al., 2006; Vincler et al., 2006
bPiDDB 34*,44,62* 2–700 0.1–3 Dwoskin et al., 2008; Papke et al., 2008; Rahman et al., 2008
DHE 42,62*,44 10–380 0.1–1 Chavez-Noriega et al., 1997; Harvey and Luetje, 1996; Papke et al., 2008; Iturriaga-Vásquez et al., 2010; Capelli
et al., 2011
MLA 7*,9*,42,62* 0.3–631 0.1–1 Verbitsky et al., 2000; Evans et al., 2003; Capelli et al., 2011; Mogg et al., 2002
ICS 9 h,910 20–166 1–10 Rothlin et al., 1999, 2003; Elgoyhen et al., 2001
aName of cholinergic agonist or antagonist.
bSelectivity for specific nAChRsubunits or subunit combinationsaspredicted fromexpression studies inXenopusoocytes,HEK cells, hair cells, or tissuewhere contributing subunitswereknown. Theasterisk (*) indicates thatnAChRcan include
additional subunits (e.g.72,910); h indicates homomeric.
cRange of nanomolar concentrations needed to achieve 50% of the maximal activation or maximal inhibition, respectively.
dRange of micromolar concentrations used in the current study.
eReferences denote subunit selectivity and measurements of sensitivity.
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gelatin and tissue sections were rinsed with 0.1 M PB. For nAChR label-
ing, preliminary treatments included a 10 min incubation in an aqueous
1% Na borohydride solution, and 1 h in a blocking solution (1% teleost
fish gelatin, 1% bovine serum albumin, and 0.5% Triton X-100 in PBS).
For other IHC processing, tissue was blocked in 5% normal donkey
serum (Jackson Immunoresearch) prepared in 0.5% Triton X-100/0.1 M
PB. After block, the tissue sections were then incubated 16–48 h with
primary antibodies (see Antibodies). Following several rounds of 0.1 M
PBwashes, sectionswere incubatedwithAlexa Fluor-conjugated second-
ary antibodies (Invitrogen) at 1:200–1:500 dilution in 0.1 M PB for 2–3 h
in the dark at RT. Sections were again washed several times with 0.1 M PB
and reactedwithDAPI (1:1000 of a 1mg/ml solution; Sigma-Aldrich) for
5 min followed by a brief wash in distilled H2O. Using an eyelash probe,
final tissue sections were transferred to Plus Slides (Fisher Scientific) and
coverslipped with SlowFade Gold (Invitrogen), Mowiol (Calbiochem),
or Vectashield (Vector Laboratories). Stained cristae were visualized on
an Olympus FV1000 (Olympus America) in the University of Rochester
Medical Center Confocal and Conventional Microscopy Core or on a
Zeiss LSM 510META (Carl Zeiss) laser scanning confocal microscope at
theUniversity of Illinois at Chicago. Confocal images were capturedwith
Olympus Fluoview or Zeiss LSM 5 Image Browser proprietary software
and exported as TIFF files. Sizing and labeling of digital TIFF imageswere
done with Adobe Photoshop and Adobe Illustrator. Efferent varicosities
on hair cells and calyx-bearing afferents were quantified manually by
rotating three-dimensional image stacks following isosurface recon-
struction and volume rendering in the image analysis software Amira
(FEI).
Antibodies. Antibodies to choline acetyltransferase (ChAT), the rate-
limiting enzyme in ACh synthesis (Millipore, AB144P, lot JC1618187;
1:100) were used to label efferent fibers and varicosities (Ohno et al.,
1993; Kong et al., 1994; Popper et al., 2002; Jordan et al., 2013). Calretinin
(Millipore, AB5054, lot LV1552190; 1:1000) was used to label type II hair
cells near the planum, calyx and dimorphic afferents in the central zone
(CZ), and bouton afferents near the torus region (Monk and Peterson,
1995; Huwe et al., 2011).Monoclonal antibodies tomyosin VIIA (Devel-
opmental Studies Hybridoma Bank, 138-1C; 1:50–1:100) and SV2 (De-
velopmental Studies Hybridoma Bank; SV2 conc.; 1:500–2000) were
developed by Dana Jo Orten and K. Buckley, respectively. Both were
obtained from the Developmental Studies Hybridoma Bank developed
under the auspices of the National Institute of Child Health and Human
Development and maintained by the University of Iowa, Department of
Biology, Iowa City, Iowa. Anti-myosin VIIA was used to label hair cells
and anti-SV2 was used to label synaptic vesicles in efferent varicosities
(Hasson et al., 1997; Pujol et al., 2014). The affinity-purified rabbit
anti-9 nAChR subunit antibody (IL-308; 1:100–1:1000) used in this
study was produced commercially (Covance Research Products) against
a 16 aa peptide sequence (SQLSRNRNNDSDLKKK) located in the large
and poorly conserved intracellular loop between membrane spanning
regions III and IV of cloned turtle9 nAChR subunit (accession number
AY768813). A cysteine attached at the N terminus of the peptide permit-
ted conjugation to keyhole limpet hemocyanin carrier. Specificity and
sensitivity of the IL-308 antibody were verified with appropriate binding
to different amounts of the9 nAChR subunit peptide solution (0.1, 0.5,
1 g) immobilized in nitrocellulose membranes (data not shown). Neg-
ative controls included both deletion of the primary antibodies and,
when available, a preabsorption control done with peptide antigen.
ISH. Oligonucleotide primers were generated from the turtle 9
nAChR gene and the partial coding sequences of the turtle 4 and 2
nAChR genes that we cloned (accession numbers AY768813, EU526107,
EU526108). Fixed turtle cristae were either reacted as wholemounts or as
40 m free-floating sections cut on a vibratome. Tissue was dehydrated
and rehydrated through a graded alcohol series (50, 70, 100, 70, 50, 25%
EtOH). Permeabilization was accomplished with 0.5% Triton X-100
overnight at 4°C and subsequently with proteinase K (0.6 mg/ml) treat-
ment for 20 min at 37°C. The enzyme was neutralized with glycine (0.1
M). The samples were postfixed in 4% PFA and acetylated in acetic anhy-
dride (0.25%) for 10 min. All preincubation and incubation steps were
done on a rotator inside a hybridization oven. A preincubation with
hybridization buffer (4 SSC, 10% dextran sulfate, 1% Denhard’s solu-
tion) was done for 1 h at 52°C. Approximately 100 ng of digoxigenin-
labeled riboprobes were then hybridized overnight at 52°C. Nonbinding
probes were rinsed using 2 SSC at 37°C for 5min, three times with 60%
formamide deionized in 0.2 SSC at 37°C for 5min, and two times in 2
SSC at RT. An RNaseA (20 ng/ml) treatment was next performed for 30
min at 37°C to digest excess single-strand RNA. After a 1 h blocking step
at RT, the tissue was incubated with alkaline-phosphatase-conjugated
sheep anti-digoxigenin antibody (Roche Molecular Biochemicals) at a
1:200 dilution in blocking solution overnight at 4°C. Tissue was washed
four times for 10 min with alkaline phosphatase buffer (Tris 100 mM,
NaCl 150 mM), pH 7.5. Preincubation in detection buffer (Tris 100 mM,
NaCl, 150 mM, MgCl2 50 mM), pH 9.5, was first performed for 2 h, and
then levamisole (2 mM; Sigma-Aldrich) was added for 30 min. The sam-
ples were reacted with NBT/BCIP color substrate (RocheMolecular Bio-
chemicals) in the dark for 4 h at RT, and subsequently overnight at 4°C.
Tissue was rinsed with alkaline phosphatase buffer (Tris 100 mM, NaCl
150 mM), pH 7.5. Some end organs were plastic-embedded for subse-
quent semithin sectioning at 4 m. Sections were then mounted in glyc-
erol, coverslipped, and examined and photographed on an Olympus
light microscope.
Western blot for9 nAChR subunit.Turtle inner ear tissue homogenate
(45g of protein) was mixed with 5 SDS loading buffer containing 2.5
M urea. Samples were denatured under two different conditions: 100°C
for 5 min or 37°C for 15 min. Each yielded a single band. After brief
centrifugation, samples were loaded on a 4–20% Tris-HCl gel, and a
molecular weight marker (Biorad) was used as a protein standard. Elec-
trophoresis was performed in Tris/SDS/glycine buffer at 120 V, until
bromophenol blue dye migrated out of the gel. The gel was placed to-
gether with nitrocellulosemembrane (Biorad) in an electroblot unit. The
transferwas performed inTris/glycine/20%methanol buffer overnight at
35 V, at 4°C. After transfer, the membrane was stained with Ponceau
stain (Sigma-Aldrich) to visualize lanes, photographed, and then washed
with 1 TBS until the stain was removed. The membrane was incubated
in 5% nonfat milk solution in 1 TBS for 2–4 h to block nonspecific
binding. After two 10 min washes in 1 TBS, the membrane was incu-
bated overnight at 4°C in an affinity-purified antibody solution (1:1000
dilution in 1 TBS with 1% BSA). The membrane was washed three
times with 1 0.05% TBS-Tween, and then incubated in secondary an-
tibody solution (goat-anti-rabbit-HRP, 1:30,000 dilution in 1 0.025%
TBS-Tween) for 1 h. Themembranewaswashed 5 10min in 1 0.05%
TBS-Tween, incubated in enhanced chemiluminescence detection re-
agents (GE Healthcare), wrapped in transparent plastic wrap and ex-
posed to Hyperfilm (GE Healthcare).
To verify the specificity of the bands, preabsorption controls were
done on the same nitrocellulose membranes, which were stripped with a
freshly prepared stripping buffer (65 mM Tris-HCl, pH 6.8, 2% SDS,
0.7% -mercaptoethanol). Membranes were incubated in this buffer for
25 min at 55°C, with occasional vigorous stirring. The membrane was
washed 3  10 min with 1 0.05% TBS-Tween, then 3  5 min in 1
TBS. After these washes, we used the identical blot protocol described
above from the point of the blocking step. In this instance, however, 3g
of purified antibody was mixed with 30g of the 9 peptide antigen and
incubated at RT for 1 h. The membrane was probed with this solution
overnight and processed as described above.
Results
Based onhair cellmorphology, the turtle posterior crista has been
partitioned into a central zone (CZ) and a peripheral zone (PZ;
Brichta and Peterson, 1994; Brichta and Goldberg, 2000a). Type
II hair cells and their bouton afferent innervation are distributed
throughout the crista in both the PZ and CZ, whereas type I hair
cells, innervated by calyx or dimorphic afferents (CD), are re-
stricted to the CZ (Fig. 1, top box). Bouton afferents may be
further subdivided into BT, BM, and BP afferents on the basis of
whether they terminate near the torus (BT), middle (BM), or
planum (BP) regions, respectively. For this study, extracellular
and intracellular sharp electrode recordings were made from BT,
BM, and CD afferents innervating the turtle posterior crista dur-
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ing electrical stimulation of vestibular efferents. As the recording
site is located within 250 m of the neuroepithelium, we moni-
tored both afferent discharge and underlying synaptic potentials.
In a total sample of 434 afferent recordings (216 CD, 95 BT, 123
BM), we examined efferent-mediated spike responses in 269
units (137CD, 56BT, 76BM) and synaptic events in 165 units (79
CD, 39 BT, 47 BM). We did not include recordings from BP
afferents in this study, as their responses to efferent stimulation
were small and their thin axons were more difficult to record
from for extended periods of time.
Afferent responses to efferent stimulation differ between
bouton and CD afferents
Responses of turtle crista afferents to efferent stimulation are
related to afferent morphology and location within the crista
neuroepithelium (Brichta and Goldberg, 2000a,b; Holt et al.,
2006b). We exploited this relationship to categorize each affer-
ent’s response to efferent stimulation as belonging to one of three
general afferent subclasses (i.e., BT, BM, and CD). Although
there is some heterogeneity in response amplitude and duration
within each subclass, it was primarily the overall response shape
that governed the categorization (Brichta and Goldberg, 2000b;
Holt et al., 2006b). Exemplars from each subclass are shown in
Figure 1. Responses of BT afferents to repeated efferent shock
trains (20 shocks at 200/s) were characterized by a profound in-
hibition of the resting discharge lasting well over 1 s before re-
turning to prestimulus rates (Fig. 1A). Relative to background
rates, the mean amplitude and duration of efferent-mediated in-
hibition in 56 BT afferents was32.0 1.9 spikes/s and 1.72
0.11 s, respectively. Delivery of the efferent shock train also in-
hibited BM afferents (Fig. 1B). Although the magnitude of the
inhibition was comparable (28.6  1.2 spikes/s, n 
 76), the
response in BM afferents differed from BT units in two distinct
ways: (1) the inhibitionwas appreciably shorter (0.413 0.012 s)
and (2) the inhibition was routinely followed by postinhibitory
excitation (PIE) averaging an increase of 16.7 0.7 spikes/s (Fig.
1B, arrowhead).
In contrast to responses of BT/BM afferents, efferent stimula-
tion excited CD afferents (Fig. 1C–F). On average, the resting
discharge in CD afferents was elevated by 45.8 1.6 spikes/s and
remained elevated for nearly 1 s (0.923  0.028 s, n 
 137). In
most CD units, the excitatory response followed a simple decay
back to baseline following termination of the efferent stimulus
(Fig. 1C). However, in 15% (20 of 137) of the population, a
small excitatory bump (Fig. 1D, asterisk) or a second excitatory
peak (Fig. 1E,F) interrupted the decay trajectory. The presence
of the second peak suggested that multiple efferent-mediated re-
sponse components were present (Brichta andGoldberg, 2000b).
There was also a correspondence in the timing of these secondary
peaks in CD units with the peak of PIE seen in BM afferents (Fig.
1B,D–F, compare arrowheads). The similar timing suggested
that these two excitatory phenomena might be attributed to the
same efferent response mechanisms. Moreover, we specifically
asked: might the presence of multiple efferent response mecha-
nisms provide a basis for further discriminating calyx from di-
morphic afferents? These observations provided the motivation
for identifying the cellular and pharmacological mechanisms un-
derlying each response in this study.
Cholinergic efferent neurons synapse with afferents and type
II hair cells
In turtle cristae, VENs synapse on three targets: calyx-bearing
afferents (i.e., calyx and dimorphic), type II hair cells, and bouton
afferents innervating type II hair cells (Fig. 2A). The synaptic
mechanisms underlying efferent-mediated inhibition of BT/BM
afferents and excitation of CD afferents have been partially char-
acterized (Holt et al., 2006b; Jordan et al., 2013). Efferent-
mediated inhibition of BT/BM afferents proceeds by way of
activating 910 nAChRs on type II hair cells whose calcium
influx subsequently activates small-conductance, calcium-
dependent SKs to hyperpolarize the hair cell (Fig. 2A, right). This
hyperpolarization inhibits the release of hair cell transmitter, pre-
sumably glutamate, onto the afferent, thereby inhibiting afferent
discharge (Holt et al., 2006a,b). PIE in BM afferents also requires
Figure 1. Effects of efferent stimulation on afferent discharge varywith unit subclass. Sche-
matic in top panel shows the relative location of bouton (BT, BM, BP) and calyx-bearing (CD)
afferents within the CZ and PZ of the turtle hemicrista. A–F, Average response histograms
generated from extracellular recordings in BT/BM (A, B) and CD afferents (C–F ) during activa-
tion of efferent fibers. Efferent shock trains (20 shocks at 200/s, black bar at t 
 0) were
delivered every 3–5 s. Total number of shock trains varied for eachunit (A, 11;B, 39;C, 41;D, 20;
E, 38; F, 36). Second excitatory bump in CD afferent is demarcatedwith an asterisk. Arrowheads
indicate the temporal alignment of PIE in a BM afferent with secondary excitatory peaks in CD
afferents.
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the activation of 910 nAChRs and subsequent hyperpolariza-
tion of type II hair cells (Holt et al., 2006b). Efferent-mediated
excitation of CD afferents is attributed to the activation of
nAChRs that directly depolarize calyx and dimorphic afferents
(Fig. 2A, left, middle). Existing pharmacological data suggested a
role for 42 and 910 nAChRs (Holt et al., 2006b; Jordan et
al., 2013). Similar nAChRs are also found on BT/BM afferents,
but inhibitory effects in type II hair cells typically mask their
activation. Despite using similar efferent synaptic mecha-
nisms, the responses of BM and dimorphic afferents to effer-
ent stimulation are dominated by activation of nAChRs on the
hair cell and afferent, respectively. Accordingly, we reasoned
that the weight of the two efferent synaptic inputs might vary
between the two afferent groups.
To assess how efferent synaptic structure varied among these
targets, turtle semicircular canal cristae were processed immuno-
histochemically with antibodies to ChAT, calretinin, andmyosin
VIIA to label efferent fibers and varicosities, calyx-bearing affer-
Figure 2. Efferent neurons innervate three distinct cellular targets in the turtle vestibular periphery. A, Illustration depicting three cholinergic efferent synapses encountered in the turtle crista.
Previous pharmacological data suggest the efferent postsynaptic complex in type II hair cells expresses910 nAChRs and SK channels whereas the postsynaptic complex on calyx, dimorphic, and
bouton afferents may include42 and910 nAChRs. I, Type I hair cells; II, type II hair cells. B–E, Confocal image projections taken from transverse sections of turtle semicircular canal crista
stained for ChAT (green), calretinin (B–D, CR,magenta),myosin VIIA (E,Myo7A,magenta), and SV2 (D, E, white).B, ChAT-positive efferent neurons profusely branch andpopulate the crista CZwith
numerous spherical varicosities. C, ChAT-positive varicosities are clustered along the parent axon and base of a calyx-bearing afferent labeled by anti-calretinin.D, Immunostaining for SV2 overlaps
with ChAT-positive varicosities in the same tissue. E, ChAT-positive varicosities are concentrated along the base of type II hair cells demarcated using antibodies againstMyo7A. These ChAT-positive
varicosities are also SV2-positive. To indicate proximity, orthogonal views (horizontal yellow lines) are presented at thebottomofC–E and side views (vertical yellow line) are shownon the right side
of E. Orthogonal views in C and D reveal that only the front half of the calyx stalk was captured in the stack. Scale bars, 5m.
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ents, and hair cells, respectively (Fig. 2B–E). Upon leaving the
stroma, ChAT-positive VEN fibers branched extensively (Fig.
2B) to give rise to many spherical varicosities that were deposited
along calyx-bearing afferents (Fig. 2B,C) and the base of type II
hair cells near the torus (Fig. 2E). In many calyx-bearing affer-
ents, a large number of ChAT-positive efferent varicosities con-
centrated along the first 50mof the axonal stalk, often stacking
up along one side (Fig. 2B,C). Colabeling with anti-ChAT and
antibodies against synaptic vesicle protein 2 (SV2) indicated that
these varicosities likely represented presynaptic release sites (Fig.
2D). Orthogonal views (dashed lines) confirmed that these vari-
cosities were in direct apposition with the calyx stalk (Fig. 2C,D,
bottom). In Figure 2C, there were 17 varicosities, immunola-
beled for both ChAT and SV2, sitting directly adjacent to the
calyx fiber. On average, there were 11.5 1.4 ChAT/SV2 var-
icosities per calyx stalk (n
 15, 3 animals). Smaller numbers of
efferent puncta were localized along the basal one-third of type II
hair cells in the middle and torus regions (Fig. 2E), averaging
4.3 0.5 varicosities per hair cell (n
 15, 3 animals).Orthogonal
and side views (dashed lines) demonstrated that the varicosities
were adjacent to the hair cell (Fig. 2E, bottom, right). Efferent
varicosities were also seen scattered along the terminal pro-
cesses of bouton afferents (data not shown). Although efferent
varicosities on bouton afferent processes were not as densely
packed as those on the calyceal stalk, those varicosities were
not counted because it was often difficult to determine
whether adjacent efferent varicosities and afferent terminals
represented a direct contact or merely a juxtaposition of effer-
ent and afferent synapses upon the base of type II hair cells
(Jordan et al., 2013). The dense efferent innervation of calyx-
bearing afferents provided one explanation as to how efferent-
mediated excitation in dimorphic afferents might obscure
efferent actions in type II hair cells. However, determining
whether the secondary excitatory peaks in CD units reflect
efferent actions on type II hair cells requires that we effectively
resolve one efferent response mechanism from the other.
910 nAChRs are not involved in efferent-mediated
excitation of CD afferents
Thepharmacological basis for distinguishing the nAChRs driving
efferent-mediated inhibition in BT/BM afferents, from those un-
derlying efferent-mediated excitation in CD afferents, has pri-
marily relied on intracellular recordings and differential blockade
by the nAChR antagonists ICS and DHE (Holt et al., 2006b).
The utility of intracellular recordings is that we can simultane-
ously monitor the effects of efferent stimulation on the afferent’s
voltage and hair cell transmitter release by analyzing ensemble
means and variances, respectively. Ensemble variance measure-
ments, taken from high-pass-filtered records, provide an assess-
ment of transmitter release from hair cells (Holt et al., 2006a,b,
2007). ICS, a potent antagonist of 910 nAChRs, completely
blocked efferent-mediated inhibition in BT/BM afferents (Table
2), as well as the underlying voltage and variance changes attrib-
uted to inhibiting transmitter release from type II hair cells (Fig.
3A). Under control conditions, the efferent stimulus hyperpolar-
ized the BT afferent and that hyperpolarization was associated
with a concomitant decrease in the ensemble variance. The ap-
plication of 10 M ICS blocked both the hyperpolarization and
variance decrease. In seven BT/BM units, ICS blocked 93% of
the efferent-mediated variance decrease, suggesting that 910
nAChRs are solely responsible for dialing back transmitter re-
lease. The variance decrease was consistent with a variation in
qrate, as a log–log regression of ensemble skew versus the cor-
rected ensemble variance for each of the seven units gave a mean
slope of 1.04 0.01.
The synaptic mechanisms governing efferent-mediated exci-
tation of CD afferents can be contrasted with those in BT/BM
afferents (Fig. 3B). During control conditions, the standard effer-
ent stimulus depolarized theCDafferent a little over 1.5mV. This
depolarization, however, was not associated with a change in the
variance that was shown earlier to depend on transmitter release
from the hair cell (Holt et al., 2006a,b). Unlike efferent-mediated
inhibition of BT/BM afferents, ICS only blocked30% of efferent-
mediated excitation (Table 2) and the underlying depolarization in
CD afferents (Holt et al., 2006b). DHE, at concentrations that do
not antagonize 910 nAChRs nor efferent-mediated inhibition in
BT/BMafferents, inhibited70%of the efferent-mediateddepolar-
ization in CD afferents (Fig. 3B). The complementary block of
efferent-mediated excitation inCDafferents by ICS andDHE sug-
gested that severalnAChRsubtypes, including910,were involved
(Holt et al., 2006b).
To answer whether efferent-mediated excitation of CD affer-
ents actually uses 910 nAChRs, we first applied 300 nM DHE
and then followed it with the coapplication of 300 nMDHE and
Table 2. Effects of cholinergic drugs on afferent responses to efferent stimulation
Druga
Range of drug concentrations
used (M)
CD BT/BM
n Control (spikes/s)b Drug (spikes/s)b %Blockc n Control (spikes/s)b Drug (spikes/s)b %Blockc
910 nAChR antagonists
BTX 1–3 4 50.8 9.6* 45.2 10.6* 11 6 26.1 3.7** 0.6 1.6 102**
-CtxRgIA 0.3–1.67 3 48.6 4.6** 56.8 5.3** 17 12 26.9 2.1** 2.1 3.1 92**
ICS 10 11 39.3 4.8** 27.3 4.0** 31** 16 30.1 2.4** 1.0 1.5 97**
MLA 0.1–3 3 47.2 6.8* 5.0 1.6 89* 11 26.6 1.3** 1.1 0.8 96**
Afferent nAChR antagonists
-CtxMII 1–2 6 43.1 8.9** 9.4 2.7* 78** 6 26.3 4.7** 24.7 4.7** 6
bPiDDB 0.1–3 11 44.0 6.5** 4.2 2.2 110** 5 30.4 4.6** 30.8 4.8** 1
DMPP 5–20 27 51.1 4.2** 5.6 2.3* 109** 10 22.1 5.4** 25.4 3.4** 15
5-iodo 0.01–3 4 62.8 19.7* 4.8 8.1 92* 5 36.1 7.0** 35.5 7.7** 2
SazA 0.01–3 5 41.4 4.2** 2.6 2.8 106** 5 36.1 4.3** 35.2 3.2** 2
Varenicline 0.1–1 4 33.1 8.6* 3.9 3.4 88* 5 28.9 4.2** 29.5 3.6** 2
aDrug effects on average spike responses in CD and BT/BM afferents, taken from the first 100 ms interval immediately following the efferent shock train (20 shocks at 200/s). Drugs were classified as either 910 or afferent nAChR
antagonists.
bMeandischarge rate during shock trainminus unstimulated background rate, before and after the indicated drug, respectively. Reported values aremean SEM in the absence (Control) and presence (Drug) of identified cholinergic agent.
A one-sample t test was used to evaluate whether these means differed from zero; level of significance indicated by asterisk.
c100 * (1 Drug/Control) where: 0–100%, drug response is smaller but of same sign as control response;100%, drug response of opposite sign from control response;0%, drug response larger but of same sign as control; statistical
tests for %Block, paired t test between Drug and Control. For all statistical tests, asterisks indicate level of significance: *p 0.05; **p 0.01.
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10 M ICS (Fig. 3B). The addition of 10
M ICS, however, failed to block the de-
polarization remaining after DHE alone
(Fig. 3B). In fact, the mean depolarization
of six CD units, during the first 80 ms in-
terval taken 20 ms after the efferent shock
train, in the presence of DHE alone was
not statistically significant from the corre-
sponding mean depolarization acquired
in the presence of DHE and ICS
(0.274 0.032mV vs 0.242 0.036mV).
These observationswere inconsistentwith
a role for 910 nAChRs, and instead
suggested that efferent-mediated excita-
tion of CD afferents simply used nAChRs
with sensitivity to both DHE and ICS.
Three further pharmacological observa-
tions supporting this assertion are pre-
sented in the next section.
The nicotinic agonist DMPP selectively
blocks efferent-mediated excitation of
CD afferents
To further pharmacologically define the nAChRs underlying
efferent-mediated excitation in turtle CD afferents, we used the
nAChR agonist DMPP. DMPP was previously shown to selec-
tively activate excitatory nAChRs, but not 910 nAChRs, in the
frog vestibular system (Bernard et al., 1985; Holt et al., 2003).We
reasoned that DMPP might work similarly in the turtle to aid in
describing the excitatory nAChRs on CD afferents. We super-
fused low concentrations of DMPP (5–20 M) while recording
the effects of the standard efferent stimulus on the resting dis-
charge of CD afferents (Fig. 4A,B). During control conditions
(superfusion of control solution), the standard efferent stimulus
rapidly and repeatedly excited the CD afferent by almost 60
spikes/s. Each excitatory transient in the rate histogram represents
the repeatedpresentationof single shock trains (Fig. 4A,Control).At
65 s (dashed line),we switched to control solution containing 20M
DMPP that, after a brief lag of 30 s, slowly excited the afferent.
DMPP-mediated excitation peaked 50 s into the application
and then slowly decayed to background levels over several
minutes despite continued DMPP delivery. Application of
DMPP also abolished ongoing efferent-mediated excitation,
suggesting that the same nAChRs contributed to both forms of
excitation (Fig. 4A,B; Table 2). Upon washout, efferent-
mediated excitation returned to near-control levels (Fig. 4B).
The most likely explanation for the loss of efferent-mediated
excitation during DMPP application is that DMPP first excited
the afferent by activating the same nAChRs recruited during
efferent stimulation. During continuous exposure, however,
DMPP presumably desensitizes these nAChRs, disabling any fur-
ther activation by DMPP or ACh released from efferents during
electrical stimulation. This phenomenon effectively allowed us to
use DMPP as an antagonist, and it is the blockade by DMPP that
is characterized in Figure 4B and Table 2.
The concentrations of DMPP used here should have little ef-
fect on efferent-mediated inhibition, as DMPP is a poor agonist
of 910 nAChRs (Sugai et al., 1992; Guth et al., 1994; Elgoyhen
et al., 2001; Sgard et al., 2002; Holt et al., 2003). Consistent with
this prediction, the application of 20 M DMPP had no signifi-
cant effect on efferent-mediated inhibition of afferent discharge
in BT/BM units (Fig. 4C; Table 2). The nicotinic agonist cytisine
(0.3–1 M) also directly excited CD afferents and subsequently
blocked efferent-mediated excitation while exhibiting little effect
on efferent-mediated inhibition of BT/BM afferents (data not
shown).
The effects of DMPP on efferent-mediated excitatory re-
sponses in CD units, and lack of effect on inhibition in BT/BM
afferents, suggested that DMPP blocks nAChRs on the afferent
while exerting little effect on the activation of 910 nAChRs
in type II hair cells. For further confirmation, we again turned
to intracellular recordings to discriminate efferent effects on
hair cells versus afferents. The application of 20 M DMPP
blocked efferent-mediated depolarization in CD afferents
(Fig. 4D). Neither the control depolarization nor the DMPP-
blocked response was associated with a change in the ensemble
variance (Fig. 4D, bottom), indicating that the depolarization
was not mediated by nAChRs on the hair cell. DMPP also
selectively antagonized nAChRs on bouton afferents without
interacting with 910 nAChRs on type II hair cells (Fig. 4E).
The initial depolarization (Fig. 4E, arrowhead) at the onset of
efferent stimulation represents direct activation of nAChRs on
the bouton afferent (Holt et al., 2006b). The application of
DMPP blocked the initial depolarization and unmasked an
efferent-mediated afferent hyperpolarization. This unmask-
ing, however, took place without significant alterations in en-
semble variance from the same time period. In four BT/BM
units, the mean depolarization and variance decrease (ex-
pressed as percentage of baseline variance) was 0.190  0.181
mV and 0.630  0.232 mV2, respectively. After DMPP, the
resulting hyperpolarization was1.840 0.452 mV while the
variance decrease was 0.910 0.026 mV2. We concluded that
DMPP antagonized excitatory nAChRs on turtle crista affer-
ents without interacting with 910 nAChRs on type II hair
cells, thereby suggesting that 910 nAChRs are not involved
in efferent-mediated excitation.
BTX and-CtxRgIA do not antagonize efferent-mediated
excitation of CD afferents
The pharmacological evidence provided thus far argues that (1)
nAChRs present on afferent processes are distinct from 910
nAChRs on type II hair cells, and (2) 910 nAChRs are not
involved in efferent-mediated excitation. To further strengthen
Figure 3. Mechanisms of efferent-mediated inhibition are distinct from efferent-mediated excitation. A, B, Intracellular re-
cordings were obtained from a BT (A) and CD (B) afferent during electrical activation of efferent fibers. Efferent shock trains (20
shocks at 200/s, black bar at t
 0)were delivered every 3–5 s. Ensemblemeans (top, left axis inmillivolts) and variances (bottom,
right axis in squaremillivolts) for each unit were based on20 shock train presentations. A, Ensemblemean and variance in a BT
afferent to the standard efferent shock train before (black traces) and during (magenta traces) application of 10 M ICS. B,
Ensemblemean and variance in a CD afferent in response to the standard efferent shock train during the sequential application of
control solution alone (Cntl, black), 300 nM DHE (magenta), and 300 nM DHBE with 10M ICS (green).
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the argument, we used MLA, BTX, and -CtxRgIA, three com-
pounds that potently antagonize910 nAChRs in other hair cell
systems (Fuchs and Murrow, 1992; Elgoyhen et al., 2001; Gout-
man et al., 2005; Ellison et al., 2006). Surprisingly, 1 M MLA
potently blocked nearly 90%or greater of both efferent-mediated
inhibition in BT/BM afferents and efferent-mediated excitation
in CD afferents (Fig. 5A,B; Table 2). Lower
concentrations of MLA (0.1–0.3 M) con-
tinuetocompletelyblock efferent-mediated
inhibition in BT/BM afferents (Table 2),
which is consistent with pharmacological
observations with 910 nAChRs (Ver-
bitsky et al., 2000; Fucile et al., 2006). Al-
though we did not conduct experiments
with lower concentrations of MLA with
efferent-mediated excitation in CD affer-
ents, the magnitude and time course of
block by 1MMLAwas similar between the
two groups, suggesting overlapping sensi-
tivities. These observations, while providing
additional pharmacological information
about afferent nAChRs, did not exclude
a role for 910 nAChRs in efferent-
mediated excitation of CD afferents. How-
ever, the remaining antagonists, BTX and
-CtxRgIA, were instructive in this regard.
BTX and -CtxRgIA blocked efferent-
mediated inhibition in BT/BM afferents
(Fig. 5C,E; Table 2) while having little effect
onefferent-mediatedexcitation inCDaffer-
ents (Fig. 5D,F; Table 2). The subsequent
application of DMPP, however, blocked
efferent-mediated excitation in the same
CD units (Fig. 5D,F), indicating that the
lack of effect with BTX or -CtxRgIA was
likely not related to issues with synaptic ac-
cess. -CtxRgIA also exerted little effect on
efferent-mediated excitation in bouton af-
ferents as noted by the unmasking of an ex-
citatory response in the BM unit after
-CtxRgIA blockade (Fig. 5E). These data
provide additional evidence that 910
nAChRs do not play a role in efferent-
mediated excitation.
Pharmacology suggests a role for 4,
6, and2 nAChR subunits in efferent-
mediated excitation of CD afferents
Selective 42*/62* agonists
The observation that efferent-mediated
excitation of CD afferents is sensitive to
low doses of DHE provided important
insight into its potential nAChR subunit
composition (Holt et al., 2006b; Table 1).
As mentioned above, 70% of the efferent-
mediated excitation in CD units was
blocked by 300 nMDHE (Fig. 3B; Holt et
al., 2006b), suggesting that IC50 estimates
were even lower. If we limit our choices to
nAChRs whose IC50 values for DHE are
300 nM, the list of possible contributing
nAChRs subunits narrows considerably.
Remaining candidates include 42* and
44* (both non-6), 62*, as well as
72 where the asterisks indicate the possible inclusion of other
subunits (Table 1). We can likely rule out 72 nAChRs since
efferent-mediated excitation in CD afferents was not potently
blocked by strychnine (Holt et al., 2006b) or BTX (Fig. 5D; Table
2). Potent blockade of efferent-mediated excitation in CD afferents
Figure 4. The nAChR agonist DMPP firstmimics and then blocks efferent-mediated excitation in CD afferents.A, The excitatory
responses of a CD afferent to repeated efferent shock trains (black bars, bottom) are shown as a three-part rate histogram before
(1) and during (2, 3) application of 20 M DMPP. Temporal gaps in graph represent10 s intervals between records. Control
solutionwas superfused during control recordings andDMPPwas started at t
 65 s (vertical dashed line) and remained on for the
rest of the trace.B, Corresponding average response histograms for control (Cntl) and DMPPwere constructed fromdata shown in
segments 1 and 3, respectively. The wash histogram was generated 15 min after returning to control solution (segment not
shown). C, Average response histogram of a BM afferent to the standard efferent shock train before and during application of 20
M DMPP. D, E, Ensemble means (top, left axis in millivolts) and variances (bottom panel, right axis in square millivolts) were
acquired from intracellular recordings of a CD andBMafferent in response to the standard efferent shock train before (black traces)
and during application of 20 M DMPP (gray traces), respectively. Arrowhead in E indicates efferent-mediated depolarization
presumablymediated by nAChRs on the afferent. In all panels, efferent shock trains (20 shocks at 200/s, black bars)were delivered
every 3 s. Ensemble means and variances as well as histograms were based on19 shock train presentations.
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byMLA(Fig. 5B) likely excludes44*nAChRs (Evans et al., 2003),
but would remain consistent with the pharmacology of both42*
and 62* nAChRs (Mogg et al., 2002; Capelli et al., 2011).
To further discriminate between remaining receptor candi-
dates, we applied several cholinergic compounds with selectivity
toward 42* and/or 62* nAChRs. These included the three
selective agonists varenicline, SazA, and 5-iodo, as well as two
antagonists, -CtxMII and bPiDDB (Table 1). We first discuss
the three agonists. Given our success achieving afferent nAChR
blockade with the nonselective nAChR agonists DMPP and cy-
tisine, we reasoned that the subtype-selective agonists (vareni-
cline, SazA, and 5-iodo) might work in a similar fashion. That is,
they might first selectively activate DHE-sensitive nAChRs on
calyx afferents and then, through competitive binding or subse-
quent desensitization of the receptors, block ongoing efferent-
mediated excitation in CD afferents. Unlike our observations
withDMPPand cytisine, we did not observe upon the application
of these three new agonists any consistent increase in the dis-
charge rate of CD afferents. But varenicline, SazA, and 5-iodo, all
at nanomolar concentrations, did block most of the efferent-
mediated increases in afferent discharge (Fig. 6A,C,E; Table 2)
while exerting little effect on efferent-mediated inhibition in
BT/BM afferents (Fig. 6B,D,F; Table 2). Presumably, these com-
pounds had reasonable access to 910 nAChRs on type II hair
cells as subsequent application of ICS completely antagonized the
inhibition in the same bouton afferents previously unaffected by
prior exposures to varenicline, SazA, and 5-iodo. In some extra-
cellular recordings fromCD afferents, pharmacological blockade
of efferent-mediated excitation unmasked an efferent-mediated
inhibitory–excitatory response (Fig. 6E). The remaining biphasic
response was remarkably similar to the typical efferent-mediated
Figure 5. Efferent-mediated activation of excitatory nAChRs on CD afferents does not re-
quire910nAChRs.A,B, Average responsehistogramofaBMandCDafferent to the standard
efferent shock train before and during application of 1 M MLA, respectively. C, Average re-
sponse histogram of a BT afferent to the standard efferent shock train before and during appli-
cation of 1MBTX. D, Average response histogram of a CD afferent to the standard efferent
shock train before and during the serial application of 3MBTX and 20MDMPP. E, Average
response histogram of a BM afferent to the standard efferent shock train before and during
application of 333 nM-CtxRgIA. F, Average response histogram of a CD afferent to the stan-
dard efferent shock train before and during serial application of 667 nM -CtxRgIA and 5M
DMPP. Efferent shock trains (20 shocks at 200/s, black bar at t
 0)were repeated every 3 s and
all histograms were based on19 shock train presentations.
Figure 6. Continuous application of selective 42*/62* nAChRs agonists selectively
block efferent-mediated excitation of CD afferents while having little effect on910 nAChR-
mediated inhibition of bouton afferents.A, C, E, Average response histograms of CD afferents to
the standard efferent shock train before and during application of 300 nM varenicline, 30 nM
SazA, and 300 nM 5-iodo, respectively.B,D, F, Average response histograms of BT/BMafferents
to the standard efferent shock train before and during application of 300 nM varenicline, 30 nM
SazA, and 300 nM 5-iodo, respectively. Each series was then followed by the application of 10
M ICS. Efferent shock trains (20 shocks at 200/s, blackbar at t
0)were repeatedevery 3 s and
all histograms were based on19 shock train presentations.
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response seen in BM afferents (Figs. 1B, 4C), particularly since
bothwere unaffected by blockers of efferent-mediated excitation.
The sensitivity to varenicline, SazA, and 5-iodo further advocated
a role for 42* and/or 62* nAChRs in efferent-mediated
excitation.
Selective62* antagonists
The preceding pharmacological observations, along with the
DHE sensitivity, suggested that 42* and/or 62* nAChRs
are involved in efferent-mediated excitation of CD afferents. To
further discriminate between these two receptor populations, we
used two selective 6*-nAChR antagonists, -CtxMII and
bPiDDB. -CtxMII is derived from the cone snail Conus magus,
and has been shown to selectively block 32* and 62*
nAChRs at low nanomolar concentrations (Cartier et al., 1996;
McIntosh et al., 2004). The inclusion of 32* nAChRs in our
system, however, is unlikely given their micromolar sensitivity to
DHE (Chavez-Noriega et al., 1997; Endo et al., 2005; Papke et
al., 2008; but see Harvey and Luetje, 1996; Table 1). Nanomolar
concentrations of-CtxMII failed to block efferent-mediated ex-
citation in turtle CD afferents (data not shown), but we reliably
saw blockade at higher concentrations. The application of 1–2
M -CtxMII blocked most of the efferent-mediated excitation
in CD afferents without affecting efferent-mediated inhibition in
BT/BM afferents (Fig. 7A,B; Table 2).
It can be argued, however, that the use of higher concentra-
tions of -CtxMII would not distinguish 62* over 42*
nAChRs (Cartier et al., 1996). To circumvent potential selectivity
issues, we also used bPiDDB, a nonpeptide antagonist selective
for62* nAChRs (Smith et al., 2010; Table 1). Nanomolar con-
centrations of bPiDDB blocked efferent-mediated excitation in
CD afferents (Fig. 7C; Table 2), yet left efferent-mediated inhibi-
tion in BT/BM afferents intact (Fig. 7D; Table 2). Estimates of
IC50 values were consistent with 62* nAChR blockade ob-
served in the CNS (Table 1). Similar to observations with 5-iodo,
blockade by bPiDDB also unmasked an inhibitory–excitatory
response (compare Figs. 6E, 7C). Together, the data presented in
Figures 6 and 7 imply that activation of 62* nAChRs underlies
efferent-mediated excitation in CD afferents.
Distinguishing calyx from dimorphic afferents in
intracellular recordings
We have shown that a number of cholinergic compounds selec-
tively block efferent-mediated excitation in CD afferents without
affecting efferent-mediated inhibition in BT/BM afferents. These
observations also suggested that the remaining efferent-mediated
inhibitory responses, seen in CD afferents following the admin-
istration of these compounds (Figs. 6E, 7C), represent the un-
challenged activation of 910 nAChRs on type II hair cells
innervating the same CD afferent. It also follows that CD affer-
ents with such postblockade signatures were likely dimorphic.
These inferences, however, are derived from extracellular record-
ings that predict what net voltages the spike encoder sees but
provide little insight into the origin of each efferent-mediated
component. For further clarification, we made measurements of
ensemble voltage and variance in intracellular recordings from
CD units during efferent stimulation and the application of cho-
linergic compounds that selectively blocked nAChRs on the af-
ferent. We used the large efferent-mediated depolarization
following the standard efferent-shock train to distinguish CD
afferents fromBT/BMafferents (Fig. 3). In 79CDunits, themean
depolarization during the 80 ms interval taken 20 ms after the
efferent shock train was 0.92  0.05 mV. This is comparable to
previously reported values and can be contrasted with hyperpo-
larizing values seen in BT/BM afferents during the same time
period (Holt et al., 2006b; Table 3).
In intracellular recordings during efferent-mediated excita-
tion of CD afferents, we encountered one of three effects on
ensemble variance: no change in variance, a variance decrease, or
a variance increase. Mean ensemble voltage and variance data are
provided in Table 3 for representative BT/BM afferents and the
three groups of CD afferents. For CD afferents, reported mean
values were tabulated from units where afferent nAChR blockers
attenuated70% of the efferent-mediated depolarization. In 35
of 79 CD units, there was no change in the ensemble variance
during efferent stimulation, reaffirming the finding that changes
in hair cell transmitter release played little, if any, role in afferent
voltage changes in this group of CD units (Fig. 3B). Within this
same group, there remained no variance change during efferent
stimulation following the addition of afferent nAChR blockers
(Fig. 4D). We labeled this first group CD_C (Table 3), as these
efferent-mediated responses would be consistent with the sole
activation of afferent nAChRs on calyx afferents (Fig. 2A).
In the second CD group (14 of 79), efferent-mediated depo-
larization was associated with a concomitant decrease in variance
similar to the variance changes seen in BT/BM afferents (com-
pare Figs. 4E, 8A). Three further similarities may be noted: (1)
selective blockade of afferent nAChRs subsequently unmasked a
hyperpolarization without affecting the variance decrease (Fig.
8A); (2) consistent with a change in qrate, a log–log regression of
ensemble skew versus the corrected ensemble variance, after af-
ferent nAChR blockade, yielded amean slope of 1.03 0.02 (n

6); and (3) consistent with the activation of 910 nAChRs on
type II hair cells, subsequent application of ICS blocked the hy-
A B
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Figure 7. Pharmacology implicates 6* nAChRs in efferent-mediated excitation of CD
afferents. A, B, Average response histogram of a CD and BT afferent to the standard
efferent shock train before and during the application of 2M -CtxMII, respectively. C,
D, Average response histogram of a CD and BM afferent to the standard efferent shock
train before and during application of 300 nM bPiDDB, respectively. Efferent shock trains
(20 shocks at 200/s, black bar at t
 0) were repeated every 3 s and all histograms were
based on20 shock train presentations.
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perpolarization and variance decrease
(Fig. 8A; n 
 4). Since these similarities
with BM afferents suggested that this
group of CD afferents received type II
hair cell input (Fig. 2E), we classified
them as dimorphic (CD_D; Table 3).
In the last group of CD afferents (22 of
79), efferent-mediated depolarization was
associated with a parallel variance in-
crease (Fig. 8B). Because there was an
efferent-mediated enhancement in the
variance, we categorized the third group
as CD_E. In contrast to efferent-mediated
variance decreases in BT/BM and CD_D
afferents, afferent nAChR blockers abol-
ished the variance increase in CD_E affer-
ents (Fig. 8B; Table 3). Unreliable estimates
of residual variance inCD_Eunits obscured
whether the efferent-mediated variance de-
crease was attributed to changes in qrate
and/orqsize. Finally, fiveCDunits showeda
mixture of the variance changes seen in
CD_D and CD_E units, while three other
CDrecordings showednovariance changeunder control conditions
but variance decreases following afferent nAChRblockade (data not
shown). These limited results suggest that in someCDunits, synap-
tic mechanisms underlying each variance change coexist.
Distinguishing calyx from dimorphic afferents in
extracellular recordings
To determine how the discharge of presumed dimorphic affer-
ents differed from calyx afferents during efferent stimulation, we
classified extracellular recordings from CD afferents as either ca-
lyx or dimorphic, based on the absence or presence of efferent-
mediated inhibition, respectively, in the overall efferent response
(Fig. 9A,B).Here, we calculated themean response histogram for
each population before and after the application of nAChR an-
tagonists (Fig. 9A,B; n 
 58, 29 each). We identified efferent-
mediated inhibition after either unmasking with afferent nAChR
antagonists (Table 2, bottom; n
 46) or as the fraction blocked
by 910 nAChR antagonists (Table 2, top, excludingMLA; n

12). Mean excitation in calyx afferents was significantly larger in
amplitude and significantly shorter in duration than dimorphic
afferents (Fig. 9A,B; Table 4), Mean prestimulus discharge rates
were also significantly higher in dimorphic afferents.
To derive a nonpharmacological estimate of mean type II hair
cell input, we subtracted the mean calyx population response
from the mean dimorphic population response (Fig. 9C, solid
line). This estimate is similar to mean inhibition–excitation in
dimorphic afferents identified pharmacologically (Fig. 9B,C,
dashed line). Differences in timing and amplitude are likely at-
tributed to incomplete block of afferent nAChRs in the pharma-
cological setting and/or interactions between efferent response
mechanisms lacking in the population estimate. Mean inhibi-
tion–excitation remaining in dimorphic afferents was nearly half
of that seen in BM afferents (compare Figs. 1B, 9C). This is likely
a product of dimorphic afferents making fewer synapses with
type II hair cells than BM afferents (Brichta and Peterson, 1994),
and that synaptic input from type I hair cells is not inhibited
during efferent stimulation.
The mean dimorphic response is interrupted along its falling
edge by a small excitatory bump (Fig. 9B, asterisk).We previously
hypothesized that this phenomenon might result from the acti-
vation of inhibitory–excitatory efferent mechanisms in type II
hair cells (Fig. 1D–F). In further exploration, efferent-mediated
Table 3. Effects of afferent nAChR blockers on ensemble responses to efferent stimulation
Unit Drug (concentration,M)b n
Measurea
Voltage (mV)c Varianced
Controle Druge %Blockf Controle Druge %Blockf
BT/BM bPiDDb (0.3), DMPP (10–20), 5iodo (0.3), SazA (0.1) 9 0.25 0.32 1.64 0.34** 313** 0.68 0.11** 0.85 0.05** 24
CD_C -CtxmII (2), bPiDDb (0.3), DHE (0.3–1), DMPP (20), SazA (0.01–0.3) 14 0.83 0.08** 0.13 0.02** 84** 0.01 0.03 0.02 0.02 81
CD_D DHE (0.1–1), DMPP (20), 5iodo (0.03), SazA (0.1) 9 1.16 0.28** 0.14 0.21 112* 0.27 0.08** 0.37 0.09** 33
CD_E bPiDDb (0.3), DHE (0.3–1), CYT (0.3), DMPP (5–20), 5iodo (0.3) 10 0.95 0.12** 0.17 0.03** 83** 0.41 0.10** 0.02 0.02 104**
aDrug effects on ensemble mean and variance responses in CD and BT/BM afferents, from the first 80 ms interval taken 20 ms after the efferent shock train (20 shocks at 200/s).
bSpecific drugs and concentrations used in each unit subclass.
cAverage voltage during shock train minus background voltage.
d(Var_eff/Var_back) 1, where Var_back and Var_eff are average ensemble variances before and during the train, respectively.
eReported values for control and drug columns are means SEM in the absence (Control) and presence (Drug) of drugs that selectively block afferent nAChRs. Mean values for CD entries were pooled from units where afferent nAChR
antagonists blocked70%of the efferent-mediated depolarization. Mean values for BT/BM units were pooled from recordings under comparable pharmacological conditions, including concentrations and time of exposure. For each unit,
ensemble measurements were tabulated from 10–25 efferent shock presentations under both control and drug conditions. A one-sample t test was used to evaluate if these means differed from zero; level of significance indicated by
asterisk.
f100 * (1Drug/Control)where: 0–100%,drug response smaller but of same sign as control response;100%,drug response of opposite sign fromcontrol response;0%,drug response larger but of same sign as control; statistical tests
for %Block, paired t test between Drug and Control. For all statistical tests, asterisks indicate level of significance: *p 0.05; **p 0.01.
Figure 8. Selective blockade of afferent nAChRs can be used to distinguish calyx from dimorphic afferents. Intracellular record-
ings were obtained from CD afferents during electrical activation of efferent fibers. Efferent shock trains (20 shocks at 200/s, black
bar at t
 0) were delivered every 3–5 s. Ensemble means (top, left axis in millivolts) and variances (bottom, right axis in square
millivolts) for each unitwere based on22 shock train presentations.A, Ensemblemean and variance in a CD afferent in response
to the standard efferent shock train during the sequential application of control solution alone (Cntl, black), 100 nM SazA (ma-
genta), and then 10M ICS (green). B, Ensemble mean and variance in a CD afferent to the standard efferent shock train before
(black) and during (magenta) application of 10M DMPP.
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excitation of the CD afferent in Figure 1E was characterized dur-
ing the application of DMPP (20 M) and -CtxRgIA (667 nM).
DMPP abolished the efferent-mediated excitation and unmasked
an inhibitory–excitatory response whose PIE would contribute
to the second excitatory peak under control conditions (Fig. 9D).
Under similar pharmacology, a clear association betweenPIE and
the second excitatory control peak was identified in 14 CD affer-
ents. That such remaining inhibitory–excitatory responses are
mediated by 910 nAChRs on type II hair cells is supported by
a sensitivity to blockade by -CtxRgIA (Fig. 9D) and ICS (data
not shown).
Immunohistochemistry with nAChR antibodies
The pharmacological observations with DHE, -CtxMII,
bPiDDB, and antagonists of 910 nAChRs suggested that
efferent-mediated excitation inCD afferents uses62* as opposed
to either 42* (non-6) or 910 nAChRs. However, we won-
dered whether 4 or 9 nAChR subunits
might coassemble with 6 and 2 in
forming functional nAChRs on calyceal
endings. There is convincing evidence for
462* nAChRs on dopaminergic neu-
rons of the ventral tegmental area (Champ-
tiaux et al., 2003), and the inclusion of the
9 nAChR subunit would be consistent
with previous IHC and -bungarotoxin
data (Ishiyama et al., 1995; Wackym et al.,
1995;Dailey et al., 2000;Luebkeet al., 2005).
To gain further insight into the partic-
ipation of 9 and 4 nAChR subunits in
efferent-mediated excitation of turtle CD
afferents, we probed turtle crista neuroep-
ithelia and vestibular ganglia using IHC
for 9, 4, and 2 nAChR subunits. We
sequenced the gene for the 9 nicotinic
receptor subunit from turtle inner ear tis-
sue and used this information to generate
a polyclonal antibody, IL-308 (see Mate-
rials andMethods). As a test of specificity,
we used IL-308 to probe Western blots of
turtle inner ear tissue homogenates and
obtained a 57 kDa band (the appropri-
ate size) for the turtle 9 nAChR subunit
(Fig. 10A). Preincubation of IL-308 with
excess peptide antigen blocked subsequent
labeling. Confocalmicrographswere gener-
ated from turtle posterior cristae stained
with IL-308 and anti-calretinin (Fig. 10C–
E). Immunostaining for IL-308 was
consistent with our pharmacological ob-
servations whereby type II hair cells (II) in
the PZ near the torus were 9-positive,
while presumed BT afferents (Fig. 10C, ar-
rowhead) innervating themwere calretinin-
positive and 9-negative. Staining patterns
of calyx afferents in the CZ resembled bou-
ton afferents in being calretinin-positive,
but 9-negative (Fig. 10D,E, arrowheads).
In the same section, type II hair cells in the
adjacent PZ were both 9-positive and
calretinin-positive (Fig. 10D,E, arrows).
These data suggest that the 9 subunit does
not contribute to direct efferent-mediated
excitation of turtle vestibular afferents.
We also used two commercially available mammalian anti-
bodies to map out the expression of 4 and 2 nAChR subunits
in turtle vestibular tissue (Fig. 10F–I). In these experiments, we
observed staining for both 4 and 2 nAChR subunits in turtle
vestibular ganglia containing the cell bodies for primary vestibu-
lar afferents (Fig. 10F,H) as well as in the crista neuroepithelium
(Fig. 10G,I). In the crista (Fig. 10G,I), staining from both anti-
bodies was generally superimposable where they labeled bouton
afferent fibers and terminals near the torus and planum (arrows),
calyx-bearing afferents in the CZ (arrowheads), and type II hair
cells near the planum (II). These observations are consistent with
a role for both 4 and 2 nAChR subunits in efferent-mediated
excitation of vestibular afferents and suggest a possible role for
42* nAChRs in planum type II hair cells. Preliminary IHC
results for the commercial antibodywe used against6, however,
were inconclusive (data not shown).
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Figure 9. Multiphasic efferent-mediated excitatory responses in CD units represent dimorphic afferents.A, CD afferents where
little to no efferent-mediated response remained following afferent nAChR blockade were classified as calyx-only afferents. An
overall average response histogram from 29 such units that were averaged before (gray, Calyx) and after (dashed line, C-Block)
nAChR blockade is shown. B, CD afferents where mixed inhibitory– excitatory responses remained following afferent nAChR
blockadewere classified asdimorphic. The responsehistograms from29CDunitsmet this criterionandwereaveragedbefore (solid
line, Dimorph) and after (dashed line, D-Block) nAChR blockade. C, Mean difference between calyx and dimorphic afferents was
estimated by subtracting the mean calyx response histogram from the mean dimorphic histogram (solid line, D minus C). This
estimate is then compared with the histogram remaining after afferent nAChR blockade in dimorphic afferents (D-Block). D,
Average response histograms of a presumeddimorphic afferent to a standard efferent shock train are shownbefore andduring the
serial applicationof 10MDMPPand then10MDMPPwith667nM-CtxRgIA. Efferent shock trains (20 shocks at 200/s, blackbar
at t
 0) were repeated every 3–5 s and histograms were based on20 shock train presentations.
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Expression of nAChR subunits in turtle vestibular tissue
Since the validity and specificity of many cholinergic receptor
antibodies have been called into question (Moser et al., 2007;
Jositsch et al., 2009), we sought additional experimental support
to validate the expression of 9, 4, and 2 in turtle vestibular
tissue. We performed ISH using primers derived from the turtle
9nAChRgeneand thepartial coding sequencesof the turtle4and
2 nAChR genes that we cloned (accession numbers AY768813,
EU526107, EU526108). ISH revealed that9mRNAexpressionwas
primarily confined to the hair cell layer (Fig. 11A, inset) where the
label was more intense near the torus and became less intense or
absent when moving toward the planum regions (Fig. 11A). In
agreementwith the immunohistochemistry, ISHdemonstrated that
turtle vestibular ganglion cells expressed the mRNA for 4 and 2
nAChR subunits (Fig. 11C,E). No label was present in ISH experi-
ments using sense probes (Fig. 11B,D,F).
Discussion
The initial impetus for this work came from pharmacological
differences in nAChRs governing efferent actions on hair cells
Table 4. Comparison of efferent-mediated excitation in calyx versus dimorphic afferents
Unit n Normalized coefficient of variationa Background discharge (sp/s)a Peak exitation (sp/s)b Mean T100 (sp/s)c Half-width (s)d Duration (s)e
Calyxf 29 0.7621 0.0267 19.3 2.0* 61.8 4.4* 54.7 4.3* 0.383 0.023 1.071 0.058*
Dimorphicf 29 0.7061 0.0235 25.7 2.3 46.9 3.1 40.1 2.9 0.477 0.040 1.376 0.071
aNormalized coefficient of variation and background discharge were calculated from 5 s period devoid of any efferent stimulus.
bPeak excitation was taken from the first 50 ms bin of the average response histogram.
cMean efferent-mediated excitation during the first 100 ms interval immediately following the efferent shock train (20 shocks at 200/s).
dTime it took the response to return to half the peak excitation.
eTime it took the response to return to background.
fStatistical test for unit response properties, unpaired t test for calyx versus dimorphic. For all statistical tests, asterisks indicate level of significance: *p 0.05; **p 0.01.
Figure10. Immunohistochemistry for9,4, and2nAChR subunits.A,Westernblotwithour IL-308antibody shows that9nAChR subunit protein is present as a singlebandof thepredicted
molecular weight (56 kDa) in turtle inner ear tissue. Preincubation with an excess of antigen peptide (IL 308 Ab peptide) blocked detection of the band. B, Schematic of turtle hemicrista
indicates the plane of sectioning for subsequent panels (Fig. 1, top). C, Antibodies to calretinin (CR) stained bouton afferent nerve fibers (green, arrowheads) innervating type II hair cells in the PZ
near the torus. IL-308 stained torus type II hair cells (magenta, II), but not associated bouton endings (green).D, E, Section through the CZ and the adjacent PZ stained for CR and9 nAChR subunit.
Calyxfibersandendings inCZ(D,green,arrowheads)are,atmost,very lightlystainedwiththe9antibody(E,magenta),whiletwotypeIIhaircells inadjacentPZ(D,white;E,magenta,arrows)arestainedwith
bothCRandthe9antibodies.F,H,Antibodies to4nAChRsubunits (F ) and2nAChRsubunits (H ) label cells investibularganglia.G, I,Antibodies to4and2nAChRsubunitsboth labelboutonafferents
near the torus andplanum (arrows), calyx-bearing afferents in the CZ (arrowheads), and type II hair cells (II) near the planum. Both panels are from the same crista section. Scale bars, 20m.
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versus afferent processes in the turtle posterior crista (Holt et al.,
2006b). In the previous study, efferent-mediated inhibition of
bouton afferents was attributed to the activation of 910
nAChRs on type II hair cells that was potently blocked by strych-
nine and ICS. In contrast, efferent-mediated excitation of CD
afferents was attributed to the direct activation of nAChRs on
calyceal endings that were partially blocked by DHE, at concen-
trations having little effect on910 nAChRs.However, nAChRs
on CD afferents were also partially blocked by ICS, suggesting
that at least two distinct populations of nAChRs, including
910, might play a role in efferent-mediated excitation.
In this study, we sought to further discriminate nAChRs that
underlie efferent-mediated excitation of CD afferents. We antic-
ipated additional pharmacology would provide insight into their
subunit composition. Using a series of selective cholinergic com-
pounds, four lines of evidence indicated that the pharmacology of
nAChRs on CD afferents is consistent with the activation of
62*, but not 910, nAChRs. First, coapplication of DHE
and ICS failed to completely block efferent-mediated depolariza-
tion in CD afferents, suggesting that the block observed with
DHE or ICS alone did not correspond to two distinct populations
of nAChRs, but rather a single population with sensitivity to both
DHE and ICS. Second, SazA, 5-iodo, varenicline, -CtxMII, and
bPiDDB potently antagonized efferent-
mediated excitation in CD afferents while
exhibiting little effect on efferent-mediated
inhibition in BT/BM afferents. Third, the
910 nAChR antagonists, BTX and
-CtxRgIA, did not block efferent-mediated
excitation in CD afferents while blocking
efferent-mediated inhibition in BT/BM affer-
ents. Finally, IHC and ISH data for the 9
nAChR subunit in turtle were consistent with
the pharmacological findings.
Insight into subunit composition of
nAChRs on CD afferents
Given that low concentrations of DHE
antagonized efferent-mediated excitation
in CD afferents (Holt et al., 2006b), it was
initially proposed that activation of 42
nAChRs was responsible. This proposal
was consistent with previous pharmacolog-
ical characterizationof42nAChRs (Har-
vey and Luetje, 1996; Chavez-Noriega et al.,
1997; Iturriaga-Va´squez et al., 2010), as
well as the expression of 4 and 2
nAChR subunits in primary vestibular
neurons (Wackym et al., 1995; Zoli et al.,
1995; Hiel et al., 1996; Anderson et al.,
1997). Furthermore, in this study, the sen-
sitivity of efferent-mediated excitation in
CD afferents to varenicline, SazA, and
5-iodo was also consistent with 42
nAChR pharmacology (Mukhin et al.,
2000; Coe et al., 2005; Xiao et al., 2006;
Zwart et al., 2008). However, since 62*
nAChRs also exhibit a similar pharmaco-
logical profile (Capelli et al., 2011; Quik
andWonnacott, 2011), we used the selec-
tive antagonists -CtxMII and bPiDDB
(McIntosh et al., 2004; Rahman et al.,
2008) to demonstrate that efferent-
mediated excitation in turtle CD afferents likely involves 62*
nAChRs.
Three further considerations are worth mentioning here.
First, -CtxMII is a potent antagonist of 62* as well as 32*
nAChRs (Cartier et al., 1996; Kuryatov et al., 2000; McIntosh et
al., 2004). Although the 3 and 2 subunits are expressed by
vestibular ganglia (Zoli et al., 1995; Hiel et al., 1996; Anderson et
al., 1997), the estimated IC50 values for DHE and bPiDDB in
blocking32* nAChRs are in themicromolar range, suggesting
that this subclass of nAChRs is unlikely to account for the
-CtxMII sensitivity of efferent-mediated excitation in turtle CD
afferents (Chavez-Noriega et al., 1997; Endo et al., 2005; Papke et
al., 2008; Rahman et al., 2008). One note of caution inmaking the
argument for 62* over 32* is that it is predicated on turtle
and mammalian 32* nAChRs having comparable pharmaco-
logical profiles. Further experimentation with selective 62*
nAChR antagonists may yield additional clarification regarding
the involvement of 32* nAChRs (Dowell et al., 2003; Pucci et
al., 2011). Second, measuring high-affinity binding of -CtxMII
in the brains of genetically modified mice, where specific nAChR
subunits have been deleted, has revealed that 62* nAChRs can
coassemble with 3, 4, and 3 subunits to form multiple
nAChR populations (Champtiaux et al., 2003; Salminen et al.,
Figure 11. Expression of 9, 4, and 2 nAChR subunit mRNA in turtle tissue. A, B, C, E, ISH using nAChR subunit-specific
antisense probes in the turtle crista (A, B) and vestibular ganglia (C, E). A, In longitudinal sections of the posterior crista (Fig. 10B,
diagram), 9 nAChR subunit mRNA was localized to the hair cell layer (HC) with more intense labeling near the torus. Inset,
Higher-magnification image of labeled hair cells taken from box. Dashed line demarcates HC and supporting cell (SC) layers. C, E,
Both 4 and 2 nAChR subunit mRNA were found in vestibular ganglia, respectively. B, D, F, Sense controls for each nAChR
subunit showed no labeling. Scale bars: inset, 20m; A, B, 50m; C–F, 20m.
Holt et al. • Selective Blockade of Vestibular Calyx Afferent nAChRs J. Neurosci., February 25, 2015 • 35(8):3625–3643 • 3639
2004, 2007). Whether efferent-mediated excitation of CD affer-
ents in turtle is driven bymultiple populations of62* nAChRs
is unknown, but IHC and ISH data regarding the expression of
these other subunits in mammalian and turtle vestibular ganglia
suggest such combinations may exist (Hiel et al., 1996; Anderson et
al., 1997). Alternatively, 42*(non-6) nAChRs might also exist
on CD afferents and account for the 20% of efferent-mediated
excitation in CD afferents unaffected by -CtxMII (Table 2).
Distinguishing calyx from dimorphic afferents
Although calyx and dimorphic afferents innervate type I hair
cells, dimorphic afferents differ anatomically by also giving rise to
bouton endings that synapse on type II hair cells (Ferna´ndez et
al., 1988, 1995; Brichta and Goldberg, 2000a; Haque et al., 2006).
In mammalian cristae, calyx afferents can be distinguished phys-
iologically from neighboring dimorphic afferents by assessing
discharge regularity and the gain and phase of each afferent’s re-
sponse to sinusoidal vestibular stimuli (Bairdet al., 1988;Lysakowski
et al., 1995). In turtle cristae, however, calyx anddimorphic afferents
are indistinguishable using any of the aforementioned physiologi-
cal properties, thus providing the previous rationale for placing
both calyx and dimorphic afferents in a single CD category
(Brichta andGoldberg, 2000a). This study shows for the first time
that efferent actions on type II hair cells can be pharmacologically
isolated and used to distinguish dimorphic from calyx afferents.
Since dimorphic and BM afferents overlap in their innervation of
type II hair cells in the CZ (Fig. 1, top), we predicted that efferent-
mediated responses in dimorphic afferents should resemble
those in BM afferents, once nAChRs on the dimorphic afferent
were blocked. Consistent with such predictions, selective block-
ade of62* nAChRs in a subset of recordings fromCDafferents
revealed a mixed inhibitory–excitatory response that was associ-
ated with parallel changes in transmitter release and blocked by
ICS or-CtxRgIA. The superimposition of PIE likely explains the
secondary excitatory phase in some CD afferents and thus it may
also be used to define those units as dimorphic.
A decrease in ensemble variance during efferent stimulation,
which has been a reliable indicator of efferent-mediated effects
on type II hair cells innervating BT/BM afferents (Holt et al.,
2006b), was also observed in approximately one-third of our in-
tracellular recordings from CD afferents. Of the three efferent
targets (i.e., type II hair cell, bouton afferent, or calyx afferent),
the variance decrease implicated the involvement of inhibitory
efferent synapses on type II hair cells innervating the same CD
afferent. As for the efferent-mediated increase in ensemble vari-
ances, we suspect that stems from excitatory nAChRs on type II
hair cells, although our current pharmacological observations
cannot eliminate the possibility that such variance changemay be
related to an increase in transmitter release from type I hair cells.
Admittedly, it is difficult to understand how efferent stimulation
would promote transmitter release from type I hair cells given the
lack of direct efferent synapses (Holt et al., 2006b). Further ex-
periments with glutamate receptor antagonists should resolve
whether variance increases are associated with an enhancement
of transmitter release (Holt et al., 2006a,b, 2007). Althoughwe do
not have direct evidence that nAChRs other than 910 nAChRs
exist on turtle type II hair cells, there is strong evidence for such
receptors in frogs (Holt et al., 2003). Like pharmacological stud-
ies in turtle, those in frog have shown that efferent-mediated
inhibition of afferent discharge is initiated by the activation of
910 nAChRs, whereas efferent-mediated excitation is medi-
ated by a group of nAChRs selectively activated by DMPP and
insensitive to 910 nAChRs antagonists (Bernard et al., 1985;
Holt et al., 2003). Our immunohistochemistry also suggests that
4 and 2 nAChR subunits might be expressed by type II hair
cells near the planum. Perhaps the CD_E category represents
dimorphic afferents innervating type II hair cells near the pla-
num. The functional significance of having distinct nAChRs in
specific cellular locations is likely tied to their electrophysiologi-
cal properties, including activation and desensitization kinetics,
ACh sensitivity, and calciumpermeability.While these have been
characterized for 910, such data regarding afferent nAChRs
are currently lacking.
Implications for mammalian efferent responses
Mammalian vestibular afferents are invariably excited by efferent
stimulation (Goldberg and Ferna´ndez, 1980; McCue and Guinan,
1994; Marlinski et al., 2004; Schneider et al., 2013). In agreement
with the pharmacological andmorphological data presented in this
study, RT-PCR and ISH studies implicate a number of nAChR
subunits in primary vestibular neurons, including 6, 4, and
2, but not 9 or 10 (Wackym et al., 1995; Hiel et al., 1996;
Anderson et al., 1997; Elgoyhen et al., 2001). However, 9 and
10 nAChR subunits are expressed in the hair cell layer, and are
functionally linked to SK channels in mammalian type II hair
cells (Hiel et al., 1996; Anderson et al., 1997; Elgoyhen et al., 2001;
Zhou et al., 2013; Yu et al., 2014). Like observations related to
turtle, these observations suggest that efferent-mediated inhibi-
tory effects are also present but may be masked by efferent-
mediated excitation. The panel of cholinergic compounds
identified in this study should be useful in parsing out the differ-
ent efferent synaptic mechanisms in mammals.
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